New hope for advanced prostate cancer: TRC003 drug trial launches
Disease control
Not yet recruiting
This early-stage trial tests a new drug called TRC003 in 90 men with a type of advanced prostate cancer that has stopped responding to standard treatments. The study aims to check the drug's safety and how well it shrinks tumors. Participants will receive up to 6 cycles of TRC003…
Phase: PHASE1, PHASE2 • Sponsor: C Ray Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:01 UTC